1Therapeutic Goods (Listing) Notice 2015 (No. 3)

---

meta-content-style-type: text/css meta-content-type: application/xhtml+xml; charset=utf-8 meta-generator: Aspose.Words for .NET 20.2

?xml version="1.0" encoding="utf-8" standalone="no"?>

 

 

Therapeutic Goods Act 1989

 

Therapeutic Goods (Listing) Notice 2015 (No. 3)

 

I, JOHN SKERRITT, National Manager of the Therapeutic Goods Administration, delegate of the Minister for Health for the purposes of subsection 9A(5) of the Therapeutic Goods Act 1989 (the Act) and acting under that provision, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods (the Register) for listed goods:

 

• preparations that contain ‘Polaprezinc’ as a therapeutically active ingredient, subject to the following condition:
  • the preparation contains a recommended daily dose of 25 milligrams or less of zinc; and
  • the preparation is for oral use only.

 

This Notice commences from the day after it is registered on the Federal Register of Legislative Instruments.

 

 

 

Dated this 25th day of June 2015

 

 

(Signed by)

 

 

John Skerritt

Delegate of the Minister for Health